Skip to content

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

News

Choose Year
Search Press Releases

Found 177 Results

March 3, 2025

Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

February 3, 2025

Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

January 30, 2025

Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics

January 13, 2025

Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders

December 20, 2024

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

December 2, 2024

Sernova Update on Strategic Initiatives

October 11, 2024

Sernova Announces Key New Executive Appointments

October 3, 2024

Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa

September 19, 2024

Sernova Appoints David Paterson Ph.D. to its Board of Directors

September 12, 2024

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

«123 4 5...10...»

IR Contact

David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

700 Collip Circle
Suite 114,
London, ON, Canada N6G 4X8
info@sernova.com

Company

About Us
Leadership
Board of Directors
Careers
Contact

Science

Our Focus
Type 1 diabetes
Pipeline
Library

Investors

Overview
News
Events
Financial Reports
Stock Information
Corporate Governance

Privacy Policy
Legal Notice

© 2025 Sernova Biotherapeutics. All rights reserved.

Scroll to Top